BACKGROUND: The purpose of this study was to describe asthma medication adherence behavior and to identify predictors of inhaled corticosteroid (ICS) underuse and inhaled beta-agonist (IBA) overuse. METHODS: Self-reported medication adherence, spirometry, various measures of status, and blood for immunoglobulin E measurement were collected on 158 subjects from a larger cohort of adults with asthma and rhinitis who were prescribed an ICS, an IBA, or both. RESULTS: There was a positive association between ICS underuse and higher forced expiratory volume in one second percent (FEV1%) predicted (P = .01) and a negative association with lower income (P = 0.04). IBA overuse was positively associated with greater perceived severity of asthma (P = 0.004) and negatively with higher education level (P = 0.02). CONCLUSIONS: Nonadherence to prescribed asthma therapy seems to be influenced by socioeconomic factors and by perceived and actual severity of disease. These factors are important to assess when trying to estimate the degree of medication adherence and its relationship to clinical presentation.
BACKGROUND: The purpose of this study was to describe asthma medication adherence behavior and to identify predictors of inhaled corticosteroid (ICS) underuse and inhaled beta-agonist (IBA) overuse. METHODS: Self-reported medication adherence, spirometry, various measures of status, and blood for immunoglobulin E measurement were collected on 158 subjects from a larger cohort of adults with asthma and rhinitis who were prescribed an ICS, an IBA, or both. RESULTS: There was a positive association between ICS underuse and higher forced expiratory volume in one second percent (FEV1%) predicted (P = .01) and a negative association with lower income (P = 0.04). IBA overuse was positively associated with greater perceived severity of asthma (P = 0.004) and negatively with higher education level (P = 0.02). CONCLUSIONS: Nonadherence to prescribed asthma therapy seems to be influenced by socioeconomic factors and by perceived and actual severity of disease. These factors are important to assess when trying to estimate the degree of medication adherence and its relationship to clinical presentation.
Authors: Andrea J Apter; Ray C Boston; Maureen George; A Lorraine Norfleet; Thomas Tenhave; James C Coyne; Kathleen Birck; Susan T Reisine; Andrew J Cucchiara; Harold I Feldman Journal: J Allergy Clin Immunol Date: 2003-06 Impact factor: 10.793
Authors: Kristin A Riekert; Arlene M Butz; Peyton A Eggleston; Karen Huss; Marilyn Winkelstein; Cynthia S Rand Journal: Pediatrics Date: 2003-03 Impact factor: 7.124
Authors: Susan L Janson; John V Fahy; Jack K Covington; Steven M Paul; Warren M Gold; Homer A Boushey Journal: Am J Med Date: 2003-12-01 Impact factor: 4.965
Authors: Maureen George; Tovia G Freedman; A Lorraine Norfleet; Harold I Feldman; Andrea J Apter Journal: J Allergy Clin Immunol Date: 2003-05 Impact factor: 10.793
Authors: Jerry L Grenard; Brett A Munjas; John L Adams; Marika Suttorp; Margaret Maglione; Elizabeth A McGlynn; Walid F Gellad Journal: J Gen Intern Med Date: 2011-05-01 Impact factor: 5.128
Authors: M Patricia Fabian; Natasha K Stout; Gary Adamkiewicz; Amelia Geggel; Cizao Ren; Megan Sandel; Jonathan I Levy Journal: Environ Health Date: 2012-09-18 Impact factor: 5.984
Authors: Mna Van Steenis; Ja Driesenaar; Jm Bensing; R Van Hulten; Pc Souverein; L Van Dijk; Pagm De Smet; Am Van Dulmen Journal: Patient Prefer Adherence Date: 2014-01-13 Impact factor: 2.711